Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The British Journal of Dermatology|February 26, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping reviewLucy Booth, Xinyi Chen, Katie Stoker, et al.Plos One|May 12, 2011
Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesAmy E Gilbert, Panagiotis Karagiannis, Tihomir Dodev, et al.Cancers|October 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat MelanomaXinyi Chen, Shabana Habib, Madalina Alexandru, et al.The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.JAMA Dermatology|April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous MelanomaSerigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.Nature Communications|May 15, 2023
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4Jitesh Chauhan, Melanie Grandits, Lais C G F Palhares, et al.Nature Communications|June 8, 2023
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanomaSilvia Crescioli, Isabel Correa, Joseph Ng, et al.Pageof 2